• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于在接受铂类化疗的癌症患者中使用唾液替代白细胞作为DNA来源以研究铂-DNA加合物的可行性研究。

A feasibility study of the use of saliva as an alternative to leukocytes as a source of DNA for the study of Pt-DNA adducts in cancer patients receiving platinum-based chemotherapy.

作者信息

Taylor Sarah E, Wood Joanna P, Thomas Anne L, Jones George D D, Reid Helen J, Sharp Barry L

机构信息

Centre for Analytical Science, Department of Chemistry, Loughborough University, Loughborough, LE11 3TU, UK.

出版信息

Anal Bioanal Chem. 2014 Dec;406(30):8033-6. doi: 10.1007/s00216-014-8274-x. Epub 2014 Nov 6.

DOI:10.1007/s00216-014-8274-x
PMID:25374124
Abstract

This note presents a comparison of the use of saliva versus leukocytes for the determination of Pt-DNA adducts obtained from patients undergoing platinum-based chemotherapy. Samples of both blood and saliva were taken pre- and post-treatment and were analysed via sector-field inductively coupled plasma mass spectrometry (SF-ICP-MS) to determine the level of Pt-DNA adducts formed. As expected, significant inter-patient variability was seen; however, a lack of correlation between the levels of adducts observed in saliva and blood samples was also observed (Pearson correlation coefficient r = -0.2598). A high yield of DNA was obtained from saliva samples, but significant difficulties were experienced in obtaining patient adherence to the saliva sampling procedure. In both leukocyte and saliva samples, not only was Pt from previous chemotherapy cycles detected, but the rapid appearance of Pt in the DNA was noted in both sample types 1 h after treatment.

摘要

本笔记介绍了在接受铂类化疗的患者中,使用唾液与白细胞来测定铂-DNA加合物的比较情况。在治疗前和治疗后采集了血液和唾液样本,并通过扇形场电感耦合等离子体质谱法(SF-ICP-MS)进行分析,以确定形成的铂-DNA加合物水平。正如预期的那样,观察到患者之间存在显著的变异性;然而,在唾液和血液样本中观察到的加合物水平之间也缺乏相关性(皮尔逊相关系数r = -0.2598)。从唾液样本中获得了高产率的DNA,但在让患者坚持唾液采样程序方面遇到了重大困难。在白细胞和唾液样本中,不仅检测到了先前化疗周期中的铂,而且在治疗后1小时,两种样本类型的DNA中都注意到铂的快速出现。

相似文献

1
A feasibility study of the use of saliva as an alternative to leukocytes as a source of DNA for the study of Pt-DNA adducts in cancer patients receiving platinum-based chemotherapy.一项关于在接受铂类化疗的癌症患者中使用唾液替代白细胞作为DNA来源以研究铂-DNA加合物的可行性研究。
Anal Bioanal Chem. 2014 Dec;406(30):8033-6. doi: 10.1007/s00216-014-8274-x. Epub 2014 Nov 6.
2
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.电感耦合等离子体质谱法定量分析接受顺铂或卡铂化疗患者外周血白细胞中的铂-DNA加合物。
Clin Cancer Res. 1996 Nov;2(11):1829-35.
3
One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.用于电感耦合等离子体质谱(ICP-MS)的1毫升湿消化法:测定经铂(II)配合物处理的细胞中的铂-DNA加合物。
Anal Bioanal Chem. 2005 Aug;382(7):1702-7. doi: 10.1007/s00216-005-3339-5. Epub 2005 Jun 16.
4
Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.采用高效液相色谱-电感耦合等离子体质谱联用技术测定人白细胞中顺铂 1,2-内源性鸟嘌呤-鸟嘌呤 DNA 加合物。
Chem Res Toxicol. 2010 Aug 16;23(8):1313-21. doi: 10.1021/tx100023c.
5
Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry.电感耦合等离子体质谱法测定人亚细胞微样本中的铂
Anal Biochem. 2007 Apr 1;363(1):135-42. doi: 10.1016/j.ab.2007.01.006. Epub 2007 Jan 10.
6
Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.应用电感耦合等离子体质谱法分析顺铂治疗患者外周血单个核细胞 DNA 提取物和组织中总铂含量。
Anal Bioanal Chem. 2008 May;391(2):577-85. doi: 10.1007/s00216-008-2034-8. Epub 2008 Apr 3.
7
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.细胞因子和药代动力学对接受顺铂治疗的儿童白细胞中铂-DNA加合物形成的影响。
Clin Cancer Res. 2001 Aug;7(8):2205-12.
8
Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.顺铂敏感和耐药细胞系中细胞摄取、DNA 掺入和加合物形成的定量评估:不同含铂药物的比较。
Biochem Pharmacol. 2015 Nov 1;98(1):69-77. doi: 10.1016/j.bcp.2015.08.112. Epub 2015 Sep 6.
9
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.顺铂脂质体包封剂型SPI-77的I期及药代动力学研究
Cancer Chemother Pharmacol. 2002 Mar;49(3):201-10. doi: 10.1007/s002800100371. Epub 2002 Jan 22.
10
Speciation of oxaliplatin adducts with DNA nucleotides.与 DNA 核苷酸的奥沙利铂加合物的形态。
Metallomics. 2011 Oct;3(10):991-1000. doi: 10.1039/c1mt00041a. Epub 2011 Aug 22.